Conference Program (PDF) - ISOQOL

Thursday
Cancer Research Center, Seattle, WA, Brian L. Egleston, Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia,
PA, Paula Diehr, Biostatistics and Health Services, University of Washington, Seattle, WA
Economic Evaluation I
Chair: David Feeny, PhD
Sovereign Suite
1727/Item Identification for the EXACT-U: A Preference-Based Measure to Report Utilities for COPD Exacerbations
Jennifer M. Petrillo, John Cairns, Donna L. Lamping, Health Services Research and Policy, London School of Hygiene & Tropical
Medicine, London, UK, Paul W. Jones, Clinical Science, St George’s, University of London, London, UK
1356/Modelling the cost-utility of screening programmes for diabetic retinopathy in India: estimating utility
values
Sarah Polack, Yasmene Alavi, Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK,
Rachapalle R. Sudhir, Vaitheeswaran Kulothungan, Preventive Ophthalmology, Sankara Nethralaya Eye Hospital, Chennai, India,
Hannah Kuper, Non-communicable Disease Epidemiology Unit, London School of Hygiene & Tropical Medicine, London, UK
1275/Estimating a Multi-Attribute Utility Function for the Health Utilities Index Mark 3 System Based on the
Preferences of Singaporeans
Nan Luo, Epidemiology and Public Health, Hwee-Lin Wee, Pharmacy, National University of Singapore, Singapore, Singapore,
Yin-Bun Cheung, Singapore Clinical Research Institute, Singapore, Singapore, David Feeny, Center for Health Research, Kaiser
Permanente Northwest, Portland, OR, Kok-Yong Fong, Rheumatology and Immunology, Singapore General Hospital, Singapore,
Singapore, Shu-Chuen Li, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia, Mandy
Ow, Pharmacy, National University of Singapore, Singapore, Singapore, David Machin, School of Health and Related Sciences,
University of Sheffield, Dorset, UK, Julian Thumboo, Rheumatology and Immunology, Singapore General Hospital, Singapore,
Singapore
1582/Beyond economic evaluation: An appropriate scoring system for EQ-5D based on real values for health
Paul Kind, Centre for Health Economics, University of York, York, UK
Mental Health
Chair: Cindy Lam, MD
Balmoral Suite
1379/Impact of Transdiagnostic Symptoms in the Measurement of Depression using the PHQ-9
Karon F. Cook, Rehabilitation Medicine, University of Washington, Seattle, Houston, TX, Charles Bombardier, Rehabilitation
Medicine, Jesse R. Fann, Psychiatry & Behavioral Sciences, University of Washington, Seattle, Seattle, WA, Kurt Kroenke,
Medicine, Indiana University School of Medicine, Indianapolis, IN
1427/Longitudinal Course of Depression Symptoms in Multiple Sclerosis
Dagmar Amtmann, Rehabilitation Medicine, University of Washington, Seattle, WA, Karon Cook, Rehabilitation Medicine, University
of Washington, Houston, TX, Kurt L. Johnson, Dawn M. Ehde, Charles H. Bombardier, Nina C. Lang, Rehabilitation Medicine,
University of Washington, Seattle, WA
1643/Screening for Major Depression Episode with the SF-12v1 in 6 European countries.
Gemma Vilagut, Carlos G Forero, Núria Ortega, Health Services Research Group, Institut Municipal d’Investigació Mèdica,
Barcelona, Spain, Ronny Bruffaerts, Department of Neurosciences, University Hospitals Gasthuisberg, Leuven, Belgium, Giovanni
de Girolamo, IRCCS Fatebenefratelli, Berscia, Italy, Ron de Graaf, Program Epidemiology, Trimbos Institute, Utrecht, The
Netherlands, Josep Maria HAro, Research and Development Unit, Parc Sanitari Sant Joan de Deu, Sant Boi de Llobregat, Spain,
Vivianne Kovess, Dpt Epidemiologie, EHESP, Paris, France, Herbert Matschinger, Department of Psychiatry, University of Leipzig,
Leipzig, Germany, Jordi Alonso, Health Services Research Group, Institut Municipal d’Investigació Mèdica, Barcelona, Spain
1355/Long-Term Health Related Quality of Life and Psychological Well-Being Outcomes in Rectal Cancer Patients
Treated with Preoperative Chemoradiotherapy
Samantha Serpentini, Clinica Chirurgica II, Ospedale/Università di Padova, Padova, Italy, Paola Del Bianco, Sperimentazioni
Cliniche e Biostatistica, Istituto Oncologico Veneto, Padova, Italy, Paola Toppan, Clinica Chirurgica II, Ospedale/Università di
Padova, Padova, Italy, Paola Zotti, Attività Clinico-Specialistica e di Supporto, Istituto Nazionale dei Tumori CRO, Aviano, Italy,
Antonino De Paoli, Oncologia Radioterapica e Diagnostica per Immagini, Istituto Nazionale Tumori, CRO, Aviano, Italy, Carlo
Capirci, Radioterapia, Azienda ULSS 18, Rovigo, Italy, Antonio Amato, Unità di ColonProctologia, Presidio Ospedaliero di Sanremo,
Sanremo, Italy, Elisa Alducci, Clinica Chirurgica II, Ospedale/Università di Padova, Padova, 35128, Gian L. De Salvo, Sperimentazioni
Cliniche e Biostatistica, Istituto Oncologico Veneto, Padova, Italy, Salvatore Pucciarelli, Clinica Chirurgica II, Ospedale/Università
di Padova, Padova, Italy
17